Linked Life Data

11113716

Source:http://linkedlifedata.com/resource/pubmed/id/11113716

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
2001-1-10
pubmed:abstractText
Erythropoietin (Epo), a growth factor produced by the kidney, is important in heart failure patients to promote oxygen delivery to tissues. Seventy-two chronic heart failure (CHF) patients at our outpatient clinic were subjected to morning serum Epo-level measurements and classified according to NYHA criteria.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
1388-9842
pubmed:author
pubmed:issnType
Print
pubmed:volume
2
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
393-8
pubmed:dateRevised
2011-6-8
pubmed:meshHeading
pubmed:year
2000
pubmed:articleTitle
Serum erythropoietin in heart failure patients treated with ACE-inhibitors or AT(1) antagonists.
pubmed:affiliation
Cardiology, Swiss Cardiovascular Center Bern, University Hospital, CH-3010 Bern, Switzerland.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't